JP2005522452A5 - - Google Patents

Download PDF

Info

Publication number
JP2005522452A5
JP2005522452A5 JP2003567882A JP2003567882A JP2005522452A5 JP 2005522452 A5 JP2005522452 A5 JP 2005522452A5 JP 2003567882 A JP2003567882 A JP 2003567882A JP 2003567882 A JP2003567882 A JP 2003567882A JP 2005522452 A5 JP2005522452 A5 JP 2005522452A5
Authority
JP
Japan
Prior art keywords
benzo
tetrahydro
azepine
alkyl
phenylsulfonamido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003567882A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005522452A (ja
Filing date
Publication date
Priority claimed from GB0203437A external-priority patent/GB0203437D0/en
Priority claimed from GB0204758A external-priority patent/GB0204758D0/en
Priority claimed from GB0212548A external-priority patent/GB0212548D0/en
Priority claimed from GB0219711A external-priority patent/GB0219711D0/en
Application filed filed Critical
Priority claimed from PCT/EP2003/001543 external-priority patent/WO2003068751A1/en
Publication of JP2005522452A publication Critical patent/JP2005522452A/ja
Publication of JP2005522452A5 publication Critical patent/JP2005522452A5/ja
Pending legal-status Critical Current

Links

JP2003567882A 2002-02-13 2003-02-13 Cns疾患の治療のための、5−ht6受容体アフィニティーを有する7−アリールスルホンアミド−2,3,4,5−テトラヒドロ−1h−ベンゾ’ジアゼピン誘導体 Pending JP2005522452A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0203437A GB0203437D0 (en) 2002-02-13 2002-02-13 Novel compounds
GB0204758A GB0204758D0 (en) 2002-02-28 2002-02-28 Novel compounds
GB0212548A GB0212548D0 (en) 2002-05-30 2002-05-30 Novel compounds
GB0219711A GB0219711D0 (en) 2002-08-23 2002-08-23 Novel compounds
PCT/EP2003/001543 WO2003068751A1 (en) 2002-02-13 2003-02-13 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5-ht6 receptor affinity for the reatment of cns disorders

Publications (2)

Publication Number Publication Date
JP2005522452A JP2005522452A (ja) 2005-07-28
JP2005522452A5 true JP2005522452A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=27739230

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003567882A Pending JP2005522452A (ja) 2002-02-13 2003-02-13 Cns疾患の治療のための、5−ht6受容体アフィニティーを有する7−アリールスルホンアミド−2,3,4,5−テトラヒドロ−1h−ベンゾ’ジアゼピン誘導体

Country Status (10)

Country Link
US (1) US20050090485A1 (cg-RX-API-DMAC7.html)
EP (1) EP1487801B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005522452A (cg-RX-API-DMAC7.html)
AR (1) AR038421A1 (cg-RX-API-DMAC7.html)
AT (1) ATE323680T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003206909A1 (cg-RX-API-DMAC7.html)
DE (1) DE60304695T2 (cg-RX-API-DMAC7.html)
ES (1) ES2260607T3 (cg-RX-API-DMAC7.html)
TW (1) TW200306843A (cg-RX-API-DMAC7.html)
WO (1) WO2003068751A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003068732A2 (en) * 2002-02-13 2003-08-21 Glaxo Group Limited Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
PL371344A1 (en) * 2002-02-13 2005-06-13 Glaxo Group Limited Benzenesulfonamide derivatives as antipsychotic agents
AR039127A1 (es) * 2002-03-27 2005-02-09 Glaxo Group Ltd Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento
MY133587A (en) 2002-05-29 2007-11-30 Glaxo Group Ltd Aromatic sulfones and their medical use
NZ544331A (en) 2003-07-22 2010-03-26 Arena Pharm Inc Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
GB0329214D0 (en) * 2003-12-17 2004-01-21 Glaxo Group Ltd Novel compounds
US8207160B2 (en) * 2003-12-18 2012-06-26 Abbott Gmbh & Co. Kg Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptor
US20050137186A1 (en) * 2003-12-18 2005-06-23 Abbott Gmbh & Co. Kg. Tetrahydrobenzazepines and their use
TW200611701A (en) * 2004-06-18 2006-04-16 Glaxo Group Ltd Novel compounds
EP1809619A1 (en) * 2004-10-21 2007-07-25 Transtech Pharma, Inc. Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
EP1910321A4 (en) * 2005-07-05 2010-09-01 Astrazeneca Ab NEW COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF, INTERMEDIATE PRODUCTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF 5-HT6-MEDIATED ILLNESSES SUCH AS ALZHEIMER'S DISEASE, COGNITIVE ILLUSTRATIONS, SCHOISOPHRENIC ASSOCIATED COGNITIVE DISORDERS, OBESITAS AND PARKINSON DISEASE
CN101258136A (zh) * 2005-07-05 2008-09-03 阿斯利康(瑞典)有限公司 新化合物、其制备方法、中间体、药物组合物和其在治疗5-ht6介导的疾病例如阿尔茨海默病、认知障碍、精神分裂症相关的认知缺损、肥胖和帕金森病中的用途
EP2120950B1 (en) * 2007-03-21 2012-07-04 Glaxo Group Limited Use of quinoline derivatives in the treatment of pain
EP2254564A1 (en) 2007-12-12 2010-12-01 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
WO2009123714A2 (en) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
CN103145619A (zh) * 2012-06-15 2013-06-12 史慎德 7-氯-6-苯磺酰氨基-2,3,4,5-四氢-1H-苯并[d]氮杂*的制备
JP2018516992A (ja) 2015-06-12 2018-06-28 アクソファント サイエンシーズ ゲーエムベーハーAxovant Sciences Gmbh レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
CN108472285A (zh) 2015-07-15 2018-08-31 阿速万科学有限责任公司 用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物
JP6929857B2 (ja) 2016-01-15 2021-09-01 ファイザー・インク 6,7,8,9−テトラヒドロ−5H−ピリド[2,3−d]アゼピンドーパミンD3リガンド

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314963A (en) * 1962-07-23 1967-04-18 Pfizer & Co C Azabenzocycloalkane-n-carboxamidines
DE3614863A1 (de) * 1986-05-02 1987-11-05 Wabco Westinghouse Fahrzeug Betaetigungseinrichtung fuer eine differentialsperre mit einem stellglied
US4978660A (en) * 1988-06-01 1990-12-18 Smithkline Beecham Corporation α-adrenergic receptor antagonists
US5006521A (en) * 1988-06-01 1991-04-09 Smithkline Beecham Corporation α-adrenergic receptor antagonists and methods of use thereas
US4959360A (en) * 1988-06-01 1990-09-25 Smithkline Beecham Corporation α-adrenergic receptor antagonists
US5939451A (en) * 1996-06-28 1999-08-17 Hoffmann-La Roche Inc. Use of sulfonamides
DZ2376A1 (fr) * 1996-12-19 2002-12-28 Smithkline Beecham Plc Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
IL133870A0 (en) * 1997-07-11 2001-04-30 Smithkline Beecham Plc Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
GB9803411D0 (en) * 1998-02-18 1998-04-15 Smithkline Beecham Plc Novel compounds
GB9926302D0 (en) * 1999-11-05 2000-01-12 Smithkline Beecham Plc Novel compounds
GB0111186D0 (en) * 2001-05-08 2001-06-27 Smithkline Beecham Plc Novel compounds
PL371344A1 (en) * 2002-02-13 2005-06-13 Glaxo Group Limited Benzenesulfonamide derivatives as antipsychotic agents
WO2003068732A2 (en) * 2002-02-13 2003-08-21 Glaxo Group Limited Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds

Similar Documents

Publication Publication Date Title
JP2005518414A5 (cg-RX-API-DMAC7.html)
US11434207B2 (en) P2X4 receptor antagonist
JP2006505623A5 (cg-RX-API-DMAC7.html)
JP2021011495A5 (cg-RX-API-DMAC7.html)
CN103038231B (zh) Hec1活性调节剂及其方法
CN110621664B (zh) 新型哌啶-2,6-二酮衍生物及其用途
JP2005527542A5 (cg-RX-API-DMAC7.html)
RU2004131641A (ru) Новые соединения
RU2005130514A (ru) 2,5- и 2,6-замещенные тетрагидроизохинолины, предназначенные для применения в качестве модуляторов 5-нт6
CN103237794B (zh) P2x4受体拮抗剂
JP2004534755A5 (cg-RX-API-DMAC7.html)
JP2009513703A5 (cg-RX-API-DMAC7.html)
CN105218532B (zh) 苯并三氮唑类化合物、制备方法和其医药用途
JP2009537542A5 (cg-RX-API-DMAC7.html)
KR20030011093A (ko) 비스-아릴술폰
JP2008506695A5 (cg-RX-API-DMAC7.html)
CN107531683A (zh) Usp7抑制剂化合物及使用方法
AR038421A1 (es) Compuesto sulfonamida de 1,2,4,5-tetrahidrobenzo (d) azepina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y su uso para preparar esta ultima
RU2005111590A (ru) 2,4-замещенные индолы и их использование в качестве модуляторов 5-гт6
RU2007116987A (ru) Новые соединения
CN102131791A (zh) 二苯并硫杂氮杂*衍生物及其用途
RU2005138147A (ru) Применение сульфонамидных производных для изготовления лекарственного средства, предназначенного для профилактики и/или лечения нарушений потребления пищи
JP2006504794A5 (cg-RX-API-DMAC7.html)
JP2005532318A5 (cg-RX-API-DMAC7.html)
CN107001267A (zh) 稠合杂环化合物